{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:50Z","timestamp":1792773410043,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clon.2026.104323","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:01:18Z","timestamp":1786633278000},"page":"104323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5858-2997","authenticated-orcid":false,"given":"R.","family":"Batool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Julve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-4505","authenticated-orcid":false,"given":"T.","family":"Mansy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5744-9820","authenticated-orcid":false,"given":"N.","family":"Mathiyalagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-7413","authenticated-orcid":false,"given":"D.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Karapanagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Josephides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7253-9128","authenticated-orcid":false,"given":"R.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5282-3888","authenticated-orcid":false,"given":"A.","family":"Hossam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Earwaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sivaramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cambell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4815-0346","authenticated-orcid":false,"given":"G.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2681-025X","authenticated-orcid":false,"given":"T.","family":"Aghadiuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Talha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9204-7144","authenticated-orcid":false,"given":"A.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-1146","authenticated-orcid":false,"given":"A.","family":"Zurgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5427-6722","authenticated-orcid":false,"given":"S.","family":"Mahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bacila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-0830","authenticated-orcid":false,"given":"H.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9317-3434","authenticated-orcid":false,"given":"T.","family":"Newsom-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104323_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.clon.2026.104323_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acs.jmedchem.9b01180","article-title":"Discovery of a Covalent Inhibitor of KRAS(G12C) (AMG 510) for the Treatment of Solid Tumors","volume":"63","author":"Lanman","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.clon.2026.104323_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clon.2026.104323_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102957","article-title":"Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) - biology, clinical results and future directions","volume":"137","author":"Attili","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clon.2026.104323_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104554","article-title":"KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies","volume":"205","author":"Liguori","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clon.2026.104323_bib6","series-title":"LUMAKRAS (sotorasib) tablets, for oral use: US prescribing information","year":"2024"},{"key":"10.1016\/j.clon.2026.104323_bib7","article-title":"Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer","year":"2022","journal-title":"Technol Appraisal Guidance [TA781]"},{"key":"10.1016\/j.clon.2026.104323_bib8","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.3390\/curroncol30070476","article-title":"Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC","volume":"30","author":"Cheema","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clon.2026.104323_bib9","series-title":"Lumykras: EPAR\u2014product information","year":"2024"},{"key":"10.1016\/j.clon.2026.104323_bib10","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for Lung Cancers with KRAS p.G12C Mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2026.104323_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial","volume":"401","author":"de Langen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2026.104323_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107293","article-title":"KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing","volume":"184","author":"Lim","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2026.104323_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cancergen.2016.03.001","article-title":"The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma","volume":"209","author":"Biernacka","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.clon.2026.104323_bib15","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.ejca.2014.04.001","article-title":"Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy","volume":"50","author":"Cserepes","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104323_bib16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2026.104323_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(21)00605-7","article-title":"Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial","volume":"23","author":"Fakih","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2026.104323_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2026.104323_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cpt.2479","article-title":"Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value","volume":"111","author":"Arlett","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clon.2026.104323_bib20","article-title":"ESMO Guidance for Reporting Oncology real-World evidence (GROW)","volume":"1","author":"Castelo-Branco","year":"2023","journal-title":"ESMO Real World Data Digital Oncol"},{"key":"10.1016\/j.clon.2026.104323_bib21","series-title":"Framework for FDA\u2019s real-world evidence Program","year":"2018"},{"key":"10.1016\/j.clon.2026.104323_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102915","article-title":"Real-world data: bridging the gap between clinical trials and practice","volume":"78","author":"Wilson","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clon.2026.104323_bib23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.clon.2026.104323_bib24","doi-asserted-by":"crossref","first-page":"S869","DOI":"10.1016\/j.annonc.2024.08.1442","article-title":"1387P Real-world data, tolerability and clinical outcomes in patients with advanced NSCLC treated with sotorasib in the UK","volume":"35","author":"Batool","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2026.104323_bib25","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1038\/s41591-025-03732-5","article-title":"Molecular determinants of sotorasib clinical efficacy in KRAS G12C-mutated non-small-cell lung cancer","volume":"31","author":"Skoulidis","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.clon.2026.104323_bib26","doi-asserted-by":"crossref","first-page":"oyae356","DOI":"10.1093\/oncolo\/oyae356","article-title":"Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer","volume":"30","author":"Skoulidis","year":"2025","journal-title":"Oncologist"},{"issue":"Suppl 7","key":"10.1016\/j.clon.2026.104323_bib27","doi-asserted-by":"crossref","first-page":"S1005","DOI":"10.1016\/j.annonc.2022.07.1116","article-title":"989P Sotorasib in advanced KRAS p.G12C-mutated non-small-cell lung cancer: safety and efficacy data from the global expanded access programme","volume":"33","author":"Awad","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2026.104323_bib28","article-title":"Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC","volume":"5","author":"Zhou","year":"2024","journal-title":"JTO Clin Res Rep"},{"issue":"Suppl 16","key":"10.1016\/j.clon.2026.104323_bib29","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1200\/JCO.2023.41.16_suppl.9083","article-title":"Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer","volume":"41","author":"Arbour","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104323_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107444","article-title":"Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program","volume":"187","author":"Passiglia","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2026.104323_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113911","article-title":"Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany","volume":"201","author":"Stratmann","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104323_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115301","article-title":"Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study","volume":"219","author":"Wislez","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104323_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2023.03.013","article-title":"Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer","volume":"186","author":"Saesen","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104323_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cpt.2461","article-title":"Marketing Authorization Applications Made to the European Medicines Agency in 2018-2019: What was the Contribution of Real-World Evidence?","volume":"111","author":"Flynn","year":"2022","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526002943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526002943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:05:44Z","timestamp":1792767944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526002943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0936655526002943"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104323","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104323"}}